Video

Founding 'Faery' Shares Resources and Inspiration Behind Blue Faery Liver Cancer Association

Author(s):

Andrea Wilson
Conference|ASCO Annual Meeting

Andrea Wilson, president and founder of Blue Faery: The Adrienne Wilson Liver Cancer Association, spoke with CURE® at the 2019 ASCO meeting about the loss of her sister and how it inspired her to found Blue Faery.

After realizing no organizations existed for patients with hepatocellular carcinoma (HCC) and their caregivers, Andrea Wilson founded Blue Faery: The Adrienne Wilson Liver Cancer Association to help prevent, treat and cure liver cancer through research, education and advocacy.

Wilson founded Blue Faery about a year and a half after her sister passed away in 2001 — just 147 days with the disease. “I knew the rate of liver cancer was going to rise in this country. I didn’t want anyone else to go through what we did.”

At the 2019 American Society of Clinical Oncology Annual Meeting, Wilson spoke about the loss of her sister and how it inspired her to found Blue Faery, while also sharing, information about the resources available, such as the online forum for patients and caregivers.

Related Videos
Image of a man with short black hair.
Image of a woman with wavy blonde hair wearing glasses.
Image of man with black hair.
Image of a woman with layered hair, wearing a bright blue cardigan.
Image of a man with short black hair.
Image of man with gray hair.
Image of woman with black hair.
Image of a man wearing a black suit and tie.
Image of a man with white hair and a white goatee.
Image of Dr. Jorge Cortes; a man with short dark hair wearing a suit.
Related Content
Image of doctor consulting man with prostate cancer.
October 22nd 2024

Treatment Side Effects, Quality of Life Factors in Prostate Cancer

Ashley Chan
It’s crucial for patients with prostate cancer to know that all treatments come with side effects, which may affect their quality of life.
cancer horizons image for podcast
December 14th 2023

Conference Highlights from the 2023 ASH Annual Meeting

Brielle Benyon Alex Biese
CURE® recently covered the 2023 American Society of Hematology Annual Meeting. In case you missed it, here is some news that came out of the conference that patients should know about.
Image of doctor consulting man.
October 18th 2024

Focal Therapy May Reduce Side Effects, Improve Quality of Life in Prostate Cancer

Darlene Dobkowski, MA
With approaches like high intensity focused ultrasound, patients with prostate cancer may experience lower rates of urinary incontinence and erectile dysfunction, an expert said.
Cancer Horizons podcast logo
December 12th 2023

Conference Highlights from SABCS

Alex Biese Brielle Benyon
CURE® recently covered the San Antonio Breast Cancer Symposium. In case you missed it, here is some news that came out of the conference that patients should know about.
Image of doctor consulting man.
October 16th 2024

Next-Generation Imaging a ‘Gold Standard’ in Metastatic Prostate Cancer

Ashley Chan
Patients with metastatic prostate cancer may have improved survival outcomes after undergoing next-generation PSMA PET imaging, an expert explained.
Image of researchers doing lab tests.
October 15th 2024

Why ‘Genetic Testing is Critical’ in Patients with Prostate Cancer

Alex Biese
As part of the CURE® Educated Patient® Prostate Cancer Summit, an expert discussed the role genetic testing plays in treatment decision-making for many.